Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrin (2005)
Auger, I,
Sebag, M,
Vincent, C,
Guis, S,
Nogueira, L,
Svensson, B,
...
No abstract available.
Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load (2005)
Balandraud, N,
Guis, S,
Meynard, JB,
Auger, I,
Sovran, H,
Roudier, J,
...
No abstract available.
HLA DRB101 and macrophagic myofasciitis (2003)
Guis, S,
Pellissier, JF,
Nicoli, F,
Reviron, D,
Mattei, JP,
Gherardi, RK,
...
No abstract available.
Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of susceptibility to malignant hyperthermia (2003)
Guis, S,
Bendahan, D,
Mattei, JP,
Kozak-Ribbens, G,
Figarella-Branger, D,
Trefouret, S,
...
No abstract available.
The shared epitope revisited: shared epitope negative HLA-DR alleles influence susceptibility to rheumatoid arthritis (2001)
Reviron, D,
Perdriger, A,
Toussirot, E,
Wendling, D,
Balandraud, N,
Guis, S,
...
No abstract available.
In Marseille, Southern France, HLA-B2702 carries higher risk than HLA-B2705 to develop ankylosing spondylitis (AS) (2001)
Guis, S,
Nielsen, W,
Boetsch, G,
Dutour, O,
Mercier, P,
Reviron, D,
...
No abstract available.